Metropolitan Life Insurance Company (MetLife)’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-749
| Closed | -$7.23K | – | 1015 |
|
|
2024
Q1 | $7.23K | Buy |
+749
| New | +$7.23K | ﹤0.01% | 2214 |
|
|
2023
Q1 | – | Sell |
-626
| Closed | -$10.6K | – | 2382 |
|
|
2022
Q4 | $10.6K | Hold |
626
| – | – | ﹤0.01% | 2267 |
|
|
2022
Q3 | $14.2K | Hold |
626
| – | – | ﹤0.01% | 2175 |
|
|
2022
Q2 | $11.3K | Buy |
+626
| New | +$11.3K | ﹤0.01% | 2292 |
|
|
2022
Q1 | – | Sell |
-2,302
| Closed | -$67.5K | – | 2451 |
|
|
2021
Q4 | $67.5K | Hold |
2,302
| – | – | ﹤0.01% | 2655 |
|
|
2021
Q3 | $151K | Buy |
+2,302
| New | +$151K | ﹤0.01% | 2285 |
|
|
2021
Q2 | – | Sell |
-2,302
| Closed | -$177K | – | 2781 |
|
|
2021
Q1 | $177K | Hold |
2,302
| – | – | ﹤0.01% | 2105 |
|
|
2020
Q4 | $203K | Hold |
2,302
| – | – | ﹤0.01% | 1925 |
|
|
2020
Q3 | $170K | Hold |
2,302
| – | – | ﹤0.01% | 1878 |
|
|
2020
Q2 | $168K | Buy |
2,302
+575
| +33% | +$42K | ﹤0.01% | 1923 |
|
|
2020
Q1 | $97K | Buy |
+1,727
| New | +$97K | ﹤0.01% | 2046 |
|